Dr. Joshua Souweine

D.D.S. | Dentist



  
  645 W Genesee Street Rd, Skaneateles
  New York, 13152-9363

  315-685-7162    Maps & Directions
Dr. Joshua Souweine is a Skaneateles, New York based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 645 W Genesee Street Rd, Skaneateles. Patients can reach him at 315-685-7162.
Dr. Joshua Souweine is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Joshua Souweine speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Joshua Souweine
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:645 W Genesee Street Rd, Skaneateles,
New York, 13152-9363
Phone:315-685-7162
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 9234435132
Enrollment ID: I20160302001295
NPI Number: 1902820145
NPI Enumeration Date: 27 Jul, 2006
NPI Last Update On: 02 Nov, 2011

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 645 W Genesee Street Rd,
Skaneateles, New York
Zip: 13152-9363
Phone Number: 315-685-7162
Patients can reach Dr. Joshua Souweine at 645 W Genesee Street Rd, Skaneateles, New York or can call to book an appointment on 315-685-7162. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.

Comments/ Reviews: